Rationale for malaria anti-toxin therapy.
Taylor-Robinson
A
A
D000328:Adult; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood / Q000276:immunology / Q000627:therapeutic use*; D002648:Child; D017261:Glycosylphosphatidylinositols / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods*; D016778:Malaria, Falciparum / Q000276:immunology / Q000469:parasitology / Q000628:therapy*; D010963:Plasmodium falciparum / Q000276:immunology* / Q000378:metabolism / Q000472:pathogenicity
D000913:Antibodies, Protozoan; D017261:Glycosylphosphatidylinositols; D007074:Immunoglobulin G